MOL-294

N/A

Report date: 2024/12/06 10:44:53

Base Information

Drug NameMOL-294
Drug Alias NameMOL-218MOL-254MOL-268MOL-294
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunosuppressantsSignal transduction pathway inhibitorsNuclear factor NF-kappa-B complex inhibitors
TargetsNuclear factor NF-kappa-B complex
Therapy Area/IndicationsAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMolecumetics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMolecumetics Ltd
Active IndicationsN/A
Inactive IndicationsAsthma

Other Information

ATC CodeN/A
Related LinksN/A